ANDA 88468, held by Pliva. Hydralazine Hydrochloride.
As of Nov 16, 2026, ANDA 88468 (Hydralazine Hydrochloride), held by Pliva, was first approved by FDA on May 1, 1984, with 16 approved supplements and 0 published complete response letters.
INDICATIONS AND USAGE Essential hypertension, alone or as an adjunct.
| Date | Submission | Status | Documents |
|---|---|---|---|
| May 1, 1984 | Original application | Approved | None posted |
| Product | Active ingredient | Marketing |
|---|---|---|
| Hydralazine Hydrochloride50MG · tablet;oral | Hydralazine Hydrochloride | RxReference drug |
| Mar 6, 2015 | Supplement 34Labeling | Approved | None posted |
| Sep 11, 2014 | Supplement 37Manufacturing | Approved | None posted |
| Jan 29, 2013 | Supplement 38Labeling · Standard review | Approved | None posted |
| Oct 11, 2001 | Supplement 14Labeling | Approved | None posted |
| Jun 8, 2001 | Supplement 13Manufacturing | Approved | None posted |
| Apr 13, 2001 | Supplement 12Manufacturing | Approved | None posted |
| Jul 7, 2000 | Supplement 11Manufacturing | Approved | None posted |
| May 11, 1994 | Supplement 10Manufacturing | Approved | None posted |
| Jul 9, 1991 | Supplement 9Manufacturing | Approved | None posted |
| Mar 25, 1988 | Supplement 8Labeling | Approved | None posted |
| Jun 9, 1986 | Supplement 7Manufacturing | Approved | None posted |
| Apr 11, 1986 | Supplement 6Manufacturing | Approved | None posted |
| Feb 21, 1986 | Supplement 5Manufacturing | Approved | None posted |
| May 22, 1985 | Supplement 4Manufacturing | Approved | None posted |
| Mar 18, 1985 | Supplement 3Manufacturing | Approved | None posted |
| Mar 18, 1985 | Supplement 2Manufacturing | Approved | None posted |
| May 1, 1984 | Original application | Approved | None posted |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters